US authority increases subsidies for single-use duodenoscopes – which benefits both Ambu and Boston Scientific

Accessing single-use duodenoscopes in the US will be a lot easier now that the US authority Center for Medicare & Medicaid Services (CMS) has granted additional reimbursement for this product type, which Boston Scientific first introduced in the US market. Since then, Danish Ambu has launched its own version in the US, and the two companies are now competing for customers.

Photo: Marcio Jose Sanchez/AP/Ritzau Scanpix

US hospitals might be getting more of an incentive to choose single-use duodenoscopes over traditional reusable scopes.

This is after the Center for Medicare & Medicaid Services (CMS), which runs US health platforms Medicare and Medicaid, has granted an additional reimbursement for single-use duodenoscopes to be used for examinations of the gall bladder and the pancreas, for example.

Already a subscriber? Log in.

Read the whole article

Get access for 14 days for free.
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
An error has occured. Please try again later.

Get full access for you and your coworkers.

Start a free company trial today

More from MedWatch

Sanofi reduces US insulin prices for the uninsured

While bills to introduce a price cap on insulin are being discussed in the US Senate, Sanofi has beaten them to the punch and reduced the price of insulin products for US diabetes patients without insurance.

Further reading

Related articles

Latest news

See all jobs